Global & Asia Pacific biochips market research report Competitive Landscape, segmentation, size, CAGR and Forecast 2017 to 2023 - Asia Pacific Market Research

Global & Asia Pacific biochips market research report Competitive Landscape, segmentation, size, CAGR and Forecast 2017 to 2023

Sale

Global & Asia Pacific biochips market research report Competitive Landscape, segmentation, size, CAGR and Forecast 2017 to 2023

$2,500$5,500

Clear
SKU: HT-20147 Categories: ,
  • Report Description
  • Additional information
  • Table of Content
  • Request for Sample

The Asia Pacific biochips market is anticipated to grow at a CAGR of 19.9% during 2016 to 2022. The market has generated the revenue $ 2081 million in 2016 and is anticipated to reach up to $ 6179 million by 2022. Biochips are basically miniaturized laboratories that can perform many of simultaneous biochemical reactions. Biochips allow investigator to rapidly monitor large numbers of biological analytes for a range of purposes. Generally, a biochip's surface area is not bigger than a fingernail. A biochip can do many of biological efforts such as decoding genes, in a few seconds.The biochip is used in protein, toxicological, and biochemical research. DNA microarray also called as biochip. Biochip is not a single product; it is a family of products that creates a technology platform. DNA-based biochips are used for two types of studies, for the detection of mutations in specific genes and to detect the differences in gene expression  between unhealthy and healthy cells. The global electronics and ICT sector has  benefits by integrating advanced scientific research in biochip technology into different medical fields such as molecular or bioinformatics biology. The broad range of biochip products and applications has propelledthe growth of the global biochips market size at a great extent. The influence of digital micro fluidic biochips is increasing in various biomedical fields, supports the detection of bioterrorism agents and the analysis of plate-based DNA arrays and gel-based. 8% populations are suffering from food allergy, globally in which approximately 6% aged 0-2 years have a food allergy.

As compare to the Asia Pacific biochips market the global biochips market has produced the revenue $ 7.63 Billion in 2016 and is expected to make up to $ 17.65 Billion by 2022. The market is anticipated to grow at a CAGR of 18.40% during 2016 to 2022 globally. The major driving forces of the global market are raising adoption of personalized medicine globally, increasing applications of biochips, rise in diagnosis & treatment of cancer. According to world health organization in 2015 in U.S. over 1658370 new cancer cases hasrecorded. As compare to America, in India in 2015 more than 666,563 death has occurred due to cancer in which 305,000 were females and 361,474 were male.In the middle of the century the Asia’s elderly population is projected to grow approx.  922.7 million. Due to rising chronic cases and deaths has raised the need of medical checkup which finally increased the biochips market. Biochips have the capability to identify cancer before its symptoms develop in human bodies. It can effortlessly detect dangerous diseases such as anthrax, smallpox, and plague in a very less time. Furthermore, biochips are gradually more finding application in veterinary diagnostics. Biochip grids are small wells and dots, Each biochip grid  contains antibodies or nucleic acid and proteins which with it can target antigen and DNA sequence. The large quantity of genetics and proteomics data linked with the requirement for discovering proteins and gene sequences in human beings is driving the biochips market. The major challenges for this market are  considered as the low commercial acceptableness owing to higher costs, availability of alternate technologies and standardization issues.

On the basis of segmentation the Asia Pacific Biochips market is segmented into its fabrication technology, type, and end user. The fabrication technology segment is divided into microarrays and micrrofluidics. The type segment is segmented into DNA chips, Lab-On-A-Chip, Protein Chips, and other arrays. The Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes are the sub segment of end user segment.

The Asia Pacific biochips segment is segmented on the basis geography into China, India Japan Korea, New Zealand. In the global biochips market North America has the major market share. Due to broad technical applications of biochips, increasing number of aging population, and early technology adopter culture, followed by Europe and Asia-Pacific. In the APAC sector China and India are consideredas anticipated emerging markets owing to its high R&D investments in the medical fields in current period. In the patient’s body for installing biochips less-invasive clinical procedures are creating higher acceptance in medical organizations. Lowering expense and rising diagnostic methods through technical developments is also driving the demand for biochips.

The major players in this biochip markets are Affymetrix,Inc , Beckman Coulter, BioMérieux, Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, PerkinElmer Agilent Technologies, and GE Healthcare, Thermo fisher scientific, Inc., EMD Millipore. Acquisition, merger, innovation and new product launch are the major technologies which help to sustain in the market. In 2016, Agilent Technologies Inc. has announced that they had completed the acquisition of iLab Solutions, LLC a market leader of cloud based solutions especially for core laboratory management. Similarly in 2016, thermo fisher, a US based company has  acquired the Affymetrix,Inc Inc, a US based company that offers genetic and cellular analytics products.

 

 

 

 

Additional information

License Type

Single User APAC License, Single User Global License, Site License APAC, Site License Global

  1. INTRODUCTION
    • EXECUTIVE SUMMARY
    • ESTIMATION METHODOLOGY
  2. MARKET OVERVIEW
    • MARKET DEFINITION AND SCOPE
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
    • PORTERS 5 FORCE MODEL
    • KEY MARKET TRENDS
      • PIPELINE ANALYSIS
      • R & D SCENARIO
      • REGULATORY FRAMEWORK
    • PARAMETRIC ANALYSIS
    • KEY MARKET INSIGHTS
      • TOP 3 EMERGING COUNTRIES
      • TOP 3 REVENUE GENERATING SEGMENTS
      • TOP 3 EMERGING SEGMENTS
    • COMPETITIVE INTELLIGENCE
      • MARKET SHARE ANALYSIS
      • TOP WINNING STRATEGIES
      • CASE STUDY: TOP COMPETITIVE MOVES
    • STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
      • INVESTMENT OPPORTUNITIES BY REGIONS
      • OPPORTUNITIES IN EMERGING APPLICATIONS
      • INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
  1. MARKET DETERMINANTS
    • MARKET DRIVER
      • RISING ADOPTION OF PERSONALIZED MEDICINE
      • INCREASE GOVERNMENT FUNDING
      • INCREASING APPLICATIONS OF BIOCHIPS
      • RISE IN DIAGNOSIS & TREATMENT OF CANCER
    • MARKET RESTRAINTS
      • VAGUE REGULATORY GUIDELINES
      • LACK OF PROPER KNOWLEDGE ABOUT BIOCHIP TECHNOLOGY
    • MARKET OPPORTUNITIES
      • INCREASING USE OF BIOCHIPS IN DIFFERENT SECTORS
      • RISING APPLICATION IN NANOFIBERS
    • MARKET CHALLENGES
      • HIGH INSTRUMENTATION COSTS
      • QUANTIFICATION OF SPECIFIC MRNA EXPRESSIONS
  1. MARKET SEGMENTATION
    • APAC BIOCHIPS MARKET BY END USER 2014 -2022 ($ MILLION)
      • APAC BIOCHIPSMARKET BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES 2014 -2022 ($ MILLION)
      • APAC BIOCHIPSMARKET BY HOSPITALS AND DIAGNOSTICS CENTERS 2014 -2022 ($ MILLION)
      • APAC BIOCHIPSMARKET BY ACADEMIC & RESEARCH INSTITUTES 2014 -2022 ($ MILLION)
      • APAC BIOCHIPSMARKET BY OTHERS 2014 -2022 ($ MILLION)
    • APAC BIOCHIPSMARKET BY TYPE 2014 -2022 ($ MILLION)
      • APAC BIOCHIPSMARKET BY DNA CHIPS 2014 -2022 ($ MILLION)
      • APAC BIOCHIPSMARKET BY LAB-ON-A-CHIP 2014 -2022 ($ MILLION)
      • APAC BIOCHIPSMARKET BY PROTEIN CHIPS PRODUCTS 2014 -2022 ($ MILLION)
      • APAC BIOCHIPSMARKET BY OTHER ARRAYS 2014 -2022 ($ MILLION)
    • APAC BIOCHIPSMARKET BY FABRICATION TECHNOLOGY 2014 -2022 ($ MILLION)
      • APAC BIOCHIPSMARKET BY  MICROARRAYS 2014 -2022 ($ MILLION)
      • APAC BIOCHIPSMARKET BY MICRO FLUIDICS 2014 -2022 ($ MILLION)
  1. GEOGRAPHIC ANALYSIS
    • CHINA BIOCHIPS MARKET 2014 -2022 ($ MILLION)
    • INDIA BIOCHIPS MARKET 2014 -2022 ($ MILLION)
    • KOREA BIOCHIPS MARKET 2014 -2022 ($ MILLION)
    • JAPAN BIOCHIPS MARKET 2014 -2022 ($ MILLION)
    • AUSTRALIA BIOCHIPS MARKET 2014 -2022 ($ MILLION)
    • THAILAND BIOCHIPS MARKET 2014 -2022 ($ MILLION)
    • NEWZEALAND BIOCHIPS MARKET 2014 -2022 ($ MILLION)
    • REST OF ASIA PACIFIC BIOCHIPS MARKET 2014 -2022 ($ MILLION)
  2. GLOBAL VS APAC MARKET “A COMPARATIVE STUDY”
    • DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • OPPORTUNITY MATRIX
    • US VS APAC MARKET
    • EUROPE VS APAC MARKET
    • ROW VS APAC MARKET
  3. COMPANY PROFILES
    • ABBOTT LABORATORIES
    • AGILENT TECHNOLOGIES, INC.
    • BIOCHAIN INSTITUTE INC
    • BIOMÉRIEUX SA
    • BIO-RAD LABORATORIES INC.
    • CEPHEID INC.
    • EMD MILLIPORE
    • FLUIDIGM CORPORATION
    • FLUIDIGM CORP
    • GE HEALTHCARE
    • ILLUMINA, INC.
    • IMGENEX
    • PERKINELMER, INC.
    • THERMO FISHER SCIENTIFIC, INC.
    • ROCHE DIAGNOSTICS

LIST OF TABLES

  1. APAC BIOCHIPSMARKET BY END USER 2014 -2022 ($ MILLION)
  2. APAC BIOCHIPSMARKET BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES BY GEOGRAPHY 2014 -2022 ($ MILLION)
  3. APAC BIOCHIPSMARKET BY HOSPITALS AND DIAGNOSTICS CENTERS BY GEOGRAPHY 2014-2022 ($ MILLIONS)
  4. APAC BIOCHIPSMARKET BY ACADEMIC & RESEARCH INSTITUTES GEOGRAPHY 2014 -2022 ($ MILLION)
  5. APAC BIOCHIPSMARKET BY OTHERS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  6. APAC BIOCHIPSMARKET BY TYPE 2014 -2022 ($ MILLION)
  7. APAC BIOCHIPSMARKET BY DNA CHIPS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  8. APAC BIOCHIPSMARKET BY LAB-ON-A-CHIP BY GEOGRAPHY 2014 -2022 ($ MILLION)
  9. APAC BIOCHIPSMARKET BY PROTEIN CHIPS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  10. APAC BIOCHIPSMARKET BY  OTHER ARRAYS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  11. APAC BIOCHIPSMARKET BY FABRICATION TECHNOLOGY 2014 -2022 ($ MILLION)
  12. APAC BIOCHIPSMARKET BY  MICROARRAYS BY GEOGRAPHY 2014 -2022 ($ MILLION)
  13. APAC BIOCHIPSMARKET BY  MICRO FLUIDICS BY GEOGRAPHY 2014 -2022 ($ MILLION)

LIST OF FIGURE

  1. APAC BIOCHIPSMARKET BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES 2014 -2022 ($ MILLION)
  2. APAC BIOCHIPSMARKET BY HOSPITALS AND DIAGNOSTICS CENTERS 2014 -2022 ($ MILLION)
  3. APAC BIOCHIPSMARKET BY ACADEMIC & RESEARCH INSTITUTES  2014-2022 ($ MILLIONS)
  4. APAC BIOCHIPSMARKET BY OTHERS 2014 -2022 ($ MILLION)
  5. APAC BIOCHIPSMARKET BY DNA CHIPS 2014 -2022 ($ MILLION)
  6. APAC BIOCHIPSMARKET BY LAB-ON-A-CHIP 2014 -2022 ($ MILLION)
  7. APAC BIOCHIPSMARKET BY PROTEIN CHIPS 2014 -2022 ($ MILLION)
  8. APAC BIOCHIPSMARKET BY OTHER ARRAYS 2014 -2022 ($ MILLION)
  9. APAC BIOCHIPSMARKET BY MICROARRAYS 2014 -2022 ($ MILLION)
  10. APAC BIOCHIPSMARKET BY MICRO FLUIDICS 2014 -2022 ($ MILLION)
  11. CHINA BIOCHIPS SYSTEM MARKET 2014 -2022 ($ MILLION)
  12. INDIA BIOCHIPS SYSTEM MARKET 2014 -2022 ($ MILLION)
  13. KOREA BIOCHIPS SYSTEM MARKET 2014 -2022 ($ MILLION)
  14. JAPAN BIOCHIPS SYSTEM MARKET 2014 -2022 ($ MILLION)
  15. AUSTRALIA BIOCHIPS SYSTEM MARKET 2014 -2022 ($ MILLION)

 

 

Name

Email

Phone

Company Name

Country

Report Title